| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |